Results 31 to 40 of about 161 (76)

CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

Cell Proliferation, Volume 58, Issue 11, November 2025.
CRISPR‐Cas systems offer transformative genome editing capabilities for precise manipulation of cellular genes. This enables two main therapeutic avenues: ex vivo modification of patient cells for re‐transplantation or direct in vivo gene targeting via advanced delivery methods.
Bahareh Farasati Far, Marziyeh Akbari, Mohammad Amin Habibi, Morteza Katavand, Sherko Nasseri   +4 more
wiley   +1 more source

Single-Cell Transcriptomics of Epstein-Barr Virus and Human Herpesvirus 6 Coinfection. [PDF]

Microbiol Resour Announc, 2023
Miranda JL.
europepmc   +1 more source

Variation in human herpesvirus 6B telomeric integration, excision, and transmission between tissues and individuals. [PDF]

Elife, 2021
Wood ML, Veal CD, Neumann R, Suárez NM, Nichols J, Parker AJ, Martin D, Romaine SP, Codd V, Samani NJ, Voors AA, Tomaszewski M, Flamand L, Davison AJ, Royle NJ.   +14 more
europepmc   +1 more source

Persistent viremia in an immunocompetent patient with inherited chromosomally integrated HHV-6B. [PDF]

Access Microbiol, 2021
Obeid M, Gakhal I, McDonald PJ.
europepmc   +1 more source

Primary HSV-2 Infection Complicated by Radiculomyelitis in a Young Immunocompetent Female Patient with Inherited Chromosomally Integrated HHV-6: A Case Report. [PDF]

Viruses, 2022
Nsoga MTN, Accorroni A, Mamin A, Schibler M.   +3 more
europepmc   +1 more source

Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches. [PDF]

J Clin Med, 2023
Baumeier C, Harms D, Aleshcheva G, Gross U, Escher F, Schultheiss HP.   +5 more
europepmc   +1 more source

Evolutionary History of Endogenous Human Herpesvirus 6 Reflects Human Migration out of Africa. [PDF]

Mol Biol Evol, 2021
Aswad A, Aimola G, Wight D, Roychoudhury P, Zimmermann C, Hill J, Lassner D, Xie H, Huang ML, Parrish NF, Schultheiss HP, Venturini C, Lager S, Smith GCS, Charnock-Jones DS, Breuer J, Greninger AL, Kaufer BB.   +17 more
europepmc   +1 more source

A viral APOBEC3 antagonist distinguishes HHV-6A from HHV-6B. [PDF]

Nat Commun
Arii J, Aktar S, Huang JR, Hirai M, Kawamura Y, Miura H, Wang B, Nagamata S, Nishimura M, Yoshikawa T, Harris RS, Mori Y.   +11 more
europepmc   +1 more source

Tracing 2500 years of human betaherpesvirus 6A and 6B diversity through ancient DNA. [PDF]

Sci Adv
Guellil M, van Dorp L, Saag L, Beneker O, Bonucci B, Sasso S, Saupe T, Solnik A, Kabral H, Allmäe R, Bates J, Dittmar JM, Ge XJ, Inskip S, Jonuks T, Karmanov VN, Khartanovich VI, Larmuseau MHD, Aneli S, Cessford C, Kriiska A, Mägi M, Malve M, De Winter N, Metspalu M, Pagani L, Robb JE, Kivisild T, Houldcroft CJ, Scheib CL, Tambets K.   +30 more
europepmc   +1 more source

Human Herpesviruses 6A and 6B in Reproductive Diseases. [PDF]

Front Immunol, 2021
Komaroff AL, Rizzo R, Ecker JL.
europepmc   +1 more source